ArticleFrontiers in pharmacology2023
Ghana's herbal medicine industry: prospects, challenges and ways forward from a developing country perspective.
Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 28 citations in OpenAlex.
- Exploring the roles of informal healthcare providers in urban settings to improve access and quality of care for the urban poor: experience from Bangladesh, Ghana, Nepal, and Nigeria.Health policy and planning · 2026Article
- Knowledge, awareness, and practices of adverse drug reaction reporting among healthcare professionals in the Ashanti region of Ghana.Indian journal of pharmacology · 2026Article
- Decolonizing global health in an age of fragmentation: reimagining equity for universal health coverage.Health policy and planning · 2026Article
- Perspectives on the formalisation of complementary and alternative medicine among current users with prostate cancer: a study at Korle-Bu Teaching Hospital, Ghana.BMC complementary medicine and therapies · 2026Article
- Strategies to promote COVID-19 vaccination in Northern Ghana: a qualitative study of stakeholders' perspectives.BMC public health · 2025Article
- Steps taken by the World Health Organization African Region Member States to standardise herbal medicines: a literature review.Journal of global health · 2025Review
- A survey on availability and composition of herbal products with beneficial health claims for chronic non-communicable diseases in Sri Lanka.BMC complementary medicine and therapies · 2025Article
- Identification of Spectral Fingerprints in Different Batches of Antimalarial Herbal Drugs Using Laser-Induced Autofluorescence and Chemometric Techniques.Journal of fluorescence · 2025Article
- Investing in traditional medicine: leveraging evidence and innovative research to strengthen the fight against malaria in Nigeria.Malaria journal · 2025Review
- Prevalence of herbal medicine consumption and regulatory compliance in some selected districts of the Bono region, Ghana.BMC complementary medicine and therapies · 2025Article
- Healthcare needs and treatment-seeking patterns of women living with obstetric fistula: a qualitative study in the Tamale Metropolis, Ghana.BMJ public health · 2025Article
- Comparative study of the registration procedure of locally manufactured herbal products in selected African countries.Frontiers in pharmacology · 2025Article
- Traditional herbal medicine regulatory implementation in Ethiopia: a qualitative study.Frontiers in pharmacology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The herbal medicine industry is one of the fastest growing industries in the world. However, no detailed assessments have been undertaken on how to achieve the benefits of this industry for developing countries. This study examined the herbal medicine industry in Ghana, with a particular focus on its prospects, challenges and ways forward. The prospects of the medicinal plant trade are huge, and include reducing the national health budget, being a source of foreign and domestic income, as well as creation of employment and poverty reduction. However, the industry is currently inundated with several challenges, such as registration of herbal medicine products and practitioners, a lack of clinical trials for herbal products, standards and quality control issues, shortage of raw plant materials for production, and insufficient scientific research to support traditional claims on the pharmacological effects of medicinal plants. I propose a number of interventions to address these challenges: increased government support, capacity building initiatives, improved regulation of herbal medicines, application of modern technology in the manufacturing of herbal products, large-scale cultivation of medicinal plants, and improved packaging and branding for herbal medicines. Both the national government and the private sector have crucial roles to deliver in the development of the herbal medicine industry in a country like Ghana.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.